CD8A and lymphoma: As expected, lymphoma samples harbored higher levels of CD8+ and CD3+ cells compared to solid tumors (median 3.3% and 17.3% for CD8 and CD3 in lymphoma versus 0.16% and 0.38% in solid tumors).